What is the structure of an amino acid that can be modified by HDACs MCAT

1. Groth A, Rocha W, Verreault A, Almouzni G: Chromatin challenges during DNA replication and repair. Cell. 2007, 128: 721-733. 10.1016/j.cell.2007.01.030.

   CAS  PubMed  Google Scholar 

2. Shahbazian MD, Grunstein M: Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem. 2007, 76: 75-100. 10.1146/annurev.biochem.76.052705.162114.

   CAS  PubMed  Google Scholar 

3. Tse C, Sera T, Wolffe AP, Hansen JC: Disruption of higher order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol Cell Biol. 1998, 18: 4629-4638.

   PubMed Central  CAS  PubMed  Google Scholar 

4. Wang X, He C, Moore SC, Ausio J: Effects of histone acetylation on the solubility and folding of the chromatin fiber. J Biol Chem. 2001, 276: 12764-12768. 10.1074/jbc.M100501200.

   CAS  PubMed  Google Scholar 

5. Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL: Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science. 2006, 311: 844-847. 10.1126/science.1124000.

   CAS  PubMed  Google Scholar 

6. Davie JR, He S, Li L, Sekhavat A, Espino P, Drobic B, Dunn KL, Sun JM, Chen HY, Yu J, Pritchard S, Wang X: Nuclear organization and chromatin dynamics: Sp1, Sp3 and histone deacetylases. Adv Enzyme Regul. 2008, 48: 189-208. 10.1016/j.advenzreg.2007.11.016.

   CAS  PubMed  Google Scholar 

7. Lee KK, Workman JL: Histone acetyltransferase complexes: one size doesn't fit all. Nat Rev Mol Cell Biol. 2007, 8: 284-295. 10.1038/nrm2145.

   CAS  PubMed  Google Scholar 

8. Yang XJ, Seto E: HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene. 2007, 26: 5310-5318. 10.1038/sj.onc.1210599.

   CAS  PubMed  Google Scholar 

9. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, Li H, Xie L, Zhao W, Yao Y, Ning ZB, Zeng R, Xiong Y, Guan KL, Zhao S, Zhao GP: Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science. 2010, 327: 1004-1007. 10.1126/science.1179687.

   PubMed Central  CAS  PubMed  Google Scholar 

10. Patel J, Pathak RR, Mujtaba S: The biology of lysine acetylation integrates transcriptional programming and metabolism. Nutr Metab (Lond). 2011, 8: 12-10.1186/1743-7075-8-12.

    CAS  Google Scholar 

11. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009, 325: 834-840. 10.1126/science.1175371.

    CAS  PubMed  Google Scholar 

12. Latham JA, Dent SY: Cross-regulation of histone modifications. Nat Struct Mol Biol. 2007, 14: 1017-1024. 10.1038/nsmb1307.

    CAS  PubMed  Google Scholar 

13. Yang XJ, Seto E: Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell. 2008, 31: 449-461. 10.1016/j.molcel.2008.07.002.

    PubMed Central  CAS  PubMed  Google Scholar 

14. Hazzalin CA, Mahadevan LC: MAPK-regulated transcription: a continuously variable gene switch?. Nat Rev Mol Cell Biol. 2002, 3: 30-40. 10.1038/nrm715.

    CAS  PubMed  Google Scholar 

15. Kouzarides T: Chromatin modifications and their function. Cell. 2007, 128: 693-705. 10.1016/j.cell.2007.02.005.

    CAS  PubMed  Google Scholar 

16. Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, Shilatifard A, Workman J, Zhang Y: New nomenclature for chromatin-modifying enzymes. Cell. 2007, 131: 633-636. 10.1016/j.cell.2007.10.039.

    CAS  PubMed  Google Scholar 

17. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB: Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003, 370: 737-749. 10.1042/BJ20021321.

    PubMed Central  CAS  PubMed  Google Scholar 

18. Gregoretti IV, Lee YM, Goodson HV: Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol. 2004, 338: 17-31. 10.1016/j.jmb.2004.02.006.

    CAS  PubMed  Google Scholar 

19. Smith KT, Workman JL: Histone deacetylase inhibitors: anticancer compounds. Int J Biochem Cell Biol. 2009, 41: 21-25. 10.1016/j.biocel.2008.09.008.

    CAS  PubMed  Google Scholar 

20. Witt O, Deubzer HE, Milde T, Oehme I: HDAC family: what are the cancer relevant targets?. Cancer Lett. 2009, 277: 8-21. 10.1016/j.canlet.2008.08.016.

    CAS  PubMed  Google Scholar 

21. Marks PA: Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. Biochim Biophys Acta. 2010, 1799: 717-725.

    PubMed Central  CAS  PubMed  Google Scholar 

22. Wiech NL, Fisher JF, Helquist P, Wiest O: Inhibition of histone deacetylases: a pharmacological approach to the treatment of non-cancer disorders. Curr Top Med Chem. 2009, 9: 257-271. 10.2174/156802609788085241.

    CAS  PubMed  Google Scholar 

23. Wagner JM, Hackanson B, Lübbert M, Jung M: Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics. 2010, 1: 117-136. 10.1007/s13148-010-0012-4.

    PubMed Central  CAS  PubMed  Google Scholar 

24. Haberland M, Montgomery RL, Olson EN: The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009, 10: 32-42. 10.1038/nrg2485.

    PubMed Central  CAS  PubMed  Google Scholar 

25. Tsai SC, Seto E: Regulation of histone deacetylase 2 by protein kinase CK2. J Biol Chem. 2002, 277: 31826-31833. 10.1074/jbc.M204149200.

    CAS  PubMed  Google Scholar 

26. Brunmeir R, Lagger S, Seiser C: Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int J Dev Biol. 2009, 53: 275-289. 10.1387/ijdb.082649rb.

    CAS  PubMed  Google Scholar 

27. Jurkin J, Zupkovitz G, Lagger S, Grausenburger R, Hagelkruys A, Kenner L, Seiser C: Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis. Cell Cycle. 2011, 10: 406-412. 10.4161/cc.10.3.14712.

    PubMed Central  CAS  PubMed  Google Scholar 

28. Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, Seiser C: Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002, 21: 2672-2681. 10.1093/emboj/21.11.2672.

    PubMed Central  CAS  PubMed  Google Scholar 

29. Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, Olson EN: Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 2007, 21: 1790-1802. 10.1101/gad.1563807.

    PubMed Central  CAS  PubMed  Google Scholar 

30. Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, Ferrari VA, Abrams CS, Gruber PJ, Epstein JA: Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity. Nat Med. 2007, 13: 324-331. 10.1038/nm1552.

    CAS  PubMed  Google Scholar 

31. Zimmermann S, Kiefer F, Prudenziati M, Spiller C, Hansen J, Floss T, Wurst W, Minucci S, Göttlicher M: Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res. 2007, 67: 9047-9054. 10.1158/0008-5472.CAN-07-0312.

    CAS  PubMed  Google Scholar 

32. MacDonald JL, Roskams AJ: Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development. Dev Dyn. 2008, 237: 2256-2267. 10.1002/dvdy.21626.

    PubMed  Google Scholar 

33. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH: HDAC2 negatively regulates memory formation and synaptic plasticity. Nature. 2009, 459: 55-60. 10.1038/nature07925.

    PubMed Central  CAS  PubMed  Google Scholar 

34. Lagger S, Meunier D, Mikula M, Brunmeir R, Schlederer M, Artaker M, Pusch O, Egger G, Hagelkruys A, Mikulits W, Weitzer G, Muellner EW, Susani M, Kenner L, Seiser C: Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans. EMBO J. 2010, 29: 3992-4007. 10.1038/emboj.2010.264.

    PubMed Central  CAS  PubMed  Google Scholar 

35. Taplick J, Kurtev V, Kroboth K, Posch M, Lechner T, Seiser C: Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1. J Mol Biol. 2001, 308: 27-38. 10.1006/jmbi.2001.4569.

    CAS  PubMed  Google Scholar 

36. Luo Y, Jian W, Stavreva D, Fu X, Hager G, Bungert J, Huang S, Qiu Y: Trans-regulation of histone deacetylase activities through acetylation. J Biol Chem. 2009, 284: 34901-34910. 10.1074/jbc.M109.038356.

    PubMed Central  CAS  PubMed  Google Scholar 

37. Chiocca S, Kurtev V, Colombo R, Boggio R, Sciurpi MT, Brosch G, Seiser C, Draetta GF, Cotten M: Histone deacetylase 1 inactivation by an adenovirus early gene product. Curr Biol. 2002, 12: 594-598. 10.1016/S0960-9822(02)00720-0.

    CAS  PubMed  Google Scholar 

38. He S, Sun JM, Li L, Davie JR: Differential intranuclear organization of transcription factors Sp1 and Sp3. Mol Biol Cell. 2005, 16: 4073-4083. 10.1091/mbc.E05-05-0388.

    PubMed Central  CAS  PubMed  Google Scholar 

39. Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C, Matthias P: Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 2010, 24: 455-469. 10.1101/gad.552310.

    PubMed Central  CAS  PubMed  Google Scholar 

40. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K: Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell. 2009, 138: 1019-1031. 10.1016/j.cell.2009.06.049.

    PubMed Central  CAS  PubMed  Google Scholar 

41. Sun JM, Chen HY, Davie JR: Differential distribution of unmodified and phosphorylated histone deacetylase 2 in chromatin. J Biol Chem. 2007, 282: 33227-33236. 10.1074/jbc.M703549200.

    CAS  PubMed  Google Scholar 

42. Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, Schreiber SL: A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci USA. 1998, 95: 3519-3524. 10.1073/pnas.95.7.3519.

    PubMed Central  CAS  PubMed  Google Scholar 

43. Yang XJ, Seto E: The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol. 2008, 9: 206-218. 10.1038/nrm2346.

    PubMed Central  CAS  PubMed  Google Scholar 

44. Silverstein RA, Ekwall K: Sin3: a flexible regulator of global gene expression and genome stability. Curr Genet. 2005, 47: 1-17. 10.1007/s00294-004-0541-5.

    CAS  PubMed  Google Scholar 

45. Hayakawa T, Nakayama J: Physiological roles of class I HDAC complex and histone demethylase. J Biomed Biotechnol. 2011, 2011: 129383-

    PubMed Central  PubMed  Google Scholar 

46. Denslow SA, Wade PA: The human Mi-2/NuRD complex and gene regulation. Oncogene. 2007, 26: 5433-5438. 10.1038/sj.onc.1210611.

    CAS  PubMed  Google Scholar 

47. Wang Y, Zhang H, Chen YP, Sun YM, Yang F, Yu WH, Liang J, Sun LY, Yang XH, Shi L, Li RF, Li YY, Zhang Y, Li Q, Yi X, Shang YF: LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell. 2009, 138: 660-672. 10.1016/j.cell.2009.05.050.

    CAS  PubMed  Google Scholar 

48. Liang J, Wan M, Zhang Y, Gu P, Xin H, Jung SY, Qin J, Wong J, Cooney AJ, Liu D, Songyang Z: Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol. 2008, 10: 731-739. 10.1038/ncb1736.

    CAS  PubMed  Google Scholar 

49. Lee MG, Wynder C, Cooch N, Shiekhattar R: An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature. 2005, 437: 432-435.

    CAS  PubMed  Google Scholar 

50. Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y: Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell. 2005, 19: 857-864. 10.1016/j.molcel.2005.08.027.

    CAS  PubMed  Google Scholar 

51. Cunliffe VT: Eloquent silence: developmental functions of class I histone deacetylases. Curr Opin Genet Dev. 2008, 18: 404-410. 10.1016/j.gde.2008.10.001.

    PubMed Central  CAS  PubMed  Google Scholar 

52. Battaglia S, Maguire O, Campbell MJ: Transcription factor co-repressors in cancer biology: roles and targeting. Int J Cancer. 2010, 126: 2511-2519.

    PubMed Central  CAS  PubMed  Google Scholar 

53. Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, Michon AM, Schlegl J, Abraham Y, Becher I, Bergamini G, Boesche M, Delling M, Dümpelfeld B, Eberhard D, Huthmacher C, Mathieson T, Poeckel D, Reader V, Strunk K, Sweetman G, Kruse U, Neubauer G, Ramsden NG, Drewes G: Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol. 2011, 29: 255-265. 10.1038/nbt.1759.

    CAS  PubMed  Google Scholar 

54. Perissi V, Jepsen K, Glass CK, Rosenfeld MG: Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet. 2010, 11: 109-123.

    CAS  PubMed  Google Scholar 

55. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W, Verdin E: Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell. 2002, 9: 45-57. 10.1016/S1097-2765(01)00429-4.

    CAS  PubMed  Google Scholar 

56. Métivier R, Penot G, Hübner MR, Reid G, Brand H, Kos M, Gannon F: Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell. 2003, 115: 751-763. 10.1016/S0092-8674(03)00934-6.

    PubMed  Google Scholar 

57. Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, Zheng S, Yenamandra A, Locke K, Yuan JL, Bonine-Summers AR, Wells CE, Kaiser JF, Washington MK, Zhao Z, Wagner FF, Sun ZW, Xia F, Holson EB, Khabele D, Hiebert SW: Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell. 2010, 18: 436-447. 10.1016/j.ccr.2010.10.022.

    PubMed Central  CAS  PubMed  Google Scholar 

58. Cedar H, Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009, 10: 295-304.

    CAS  PubMed  Google Scholar 

59. Sharma S, Kelly TK, Jones PA: Epigenetics in cancer. Carcinogenesis. 2010, 31: 27-36. 10.1093/carcin/bgp220.

    PubMed Central  CAS  PubMed  Google Scholar 

60. Verdin E, Dequiedt F, Kasler HG: Class II histone deacetylases: versatile regulators. Trends Genet. 2003, 19: 286-293. 10.1016/S0168-9525(03)00073-8.

    CAS  PubMed  Google Scholar 

61. Parra M, Verdin E: Regulatory signal transduction pathways for class IIa histone deacetylases. Curr Opin Pharmacol. 2010, 10: 454-460. 10.1016/j.coph.2010.04.004.

    CAS  PubMed  Google Scholar 

62. Bradner JE, West N, Grachan ML, Greenberg EF, Haggarty SJ, Warnow T, Mazitschek R: Chemical phylogenetics of histone deacetylases. Nat Chem Biol. 2010, 6: 238-243.

    PubMed Central  CAS  PubMed  Google Scholar 

63. Martin M, Kettmann R, Dequiedt F: Class IIa histone deacetylases: regulating the regulators. Oncogene. 2007, 26: 5450-5467. 10.1038/sj.onc.1210613.

    CAS  PubMed  Google Scholar 

64. Martin M, Kettmann R, Dequiedt F: Class IIa histone deacetylases: conducting development and differentiation. Int J Dev Biol. 2009, 53: 291-301. 10.1387/ijdb.082698mm.

    CAS  PubMed  Google Scholar 

65. Valenzuela-Fernández A, Cabrero JR, Serrador JM, Sánchez-Madrid F: HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol. 2008, 18: 291-297. 10.1016/j.tcb.2008.04.003.

    PubMed  Google Scholar 

66. Li G, Jiang H, Chang M, Xie H, Hu L: HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases. J Neurol Sci. 2011, 304: 1-8. 10.1016/j.jns.2011.02.017.

    CAS  PubMed  Google Scholar 

67. Aldana-Masangkay GI, Sakamoto KM: The role of HDAC6 in cancer. J Biomed Biotechnol. 2011, 2011: 875824-

    PubMed Central  PubMed  Google Scholar 

68. Villagra A, Sotomayor EM, Seto E: Histone deacetylases and the immunological network: implications in cancer and inflammation. Oncogene. 2010, 29: 157-173. 10.1038/onc.2009.334.

    CAS  PubMed  Google Scholar 

69. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP: Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature. 1999, 401: 188-193. 10.1038/43710.

    CAS  PubMed  Google Scholar 

70. Bertrand P: Inside HDAC with HDAC inhibitors. Eur J Med Chem. 2010, 45: 2095-2116. 10.1016/j.ejmech.2010.02.030.

    CAS  PubMed  Google Scholar 

71. Sekhavat A, Sun JM, Davie JR: Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Biochem Cell Biol. 2007, 85: 751-758. 10.1139/O07-145.

    CAS  PubMed  Google Scholar 

72. Smith KT, Martin-Brown SA, Florens L, Washburn MP, Workman JL: Deacetylase inhibitors dissociate the histone-targeting ING2 subunit from the Sin3 complex. Chem Biol. 2010, 17: 65-74. 10.1016/j.chembiol.2009.12.010.

    PubMed Central  CAS  PubMed  Google Scholar 

73. Salisbury CM, Cravatt BF: Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc Natl Acad Sci USA. 2007, 104: 1171-1176. 10.1073/pnas.0608659104.

    PubMed Central  CAS  PubMed  Google Scholar 

74. Glozak MA, Sengupta N, Zhang X, Seto E: Acetylation and deacetylation of non-histone proteins. Gene. 2005, 363: 15-23.

    CAS  PubMed  Google Scholar 

75. Wanczyk M, Roszczenko K, Marcinkiewicz K, Bojarczuk K, Kowara M, Winiarska M: HDACi: going through the mechanisms. Front Biosci. 2011, 16: 340-359. 10.2741/3691.

    CAS  Google Scholar 

76. Gui CY, Ngo L, Xu WS, Richon VM, Marks PA: Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci USA. 2004, 101: 1241-1246. 10.1073/pnas.0307708100.

    PubMed Central  CAS  PubMed  Google Scholar 

77. Simboeck E, Sawicka A, Zupkovitz G, Senese S, Winter S, Dequiedt F, Ogris E, Di Croce L, Chiocca S, Seiser C: A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. J Biol Chem. 2010, 285: 41062-41073. 10.1074/jbc.M110.184481.

    PubMed Central  CAS  PubMed  Google Scholar 

78. Drobic B, Pérez-Cadahía B, Yu J, Kung SK, Davie JR: Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Res. 2010, 38: 3196-3208. 10.1093/nar/gkq030.

    PubMed Central  CAS  PubMed  Google Scholar 

79. Zhao Y, Lu S, Wu L, Chai G, Wang H, Chen Y, Sun J, Yu Y, Zhou W, Zheng Q, Wu M, Otterson GA, Zhu WG: Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21Waf1/Cip1. Mol Cell Biol. 2006, 26: 2782-2790. 10.1128/MCB.26.7.2782-2790.2006.

    PubMed Central  CAS  PubMed  Google Scholar 

80. Radhakrishnan SK, Gierut J, Gartel AL: Multiple alternate p21 transcripts are regulated by p53 in human cells. Oncogene. 2006, 25: 1812-1815. 10.1038/sj.onc.1209195.

    CAS  PubMed  Google Scholar 

81. Chen Y, Zhang L, Jones KA: SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing. Genes Dev. 2011, 25: 701-716. 10.1101/gad.2002611.

    PubMed Central  CAS  PubMed  Google Scholar 

82. Edmond V, Brambilla C, Brambilla E, Gazzeri S, Eymin B: SRSF2 is required for sodium butyrate-mediated p21WAF1 induction and premature senescence in human lung carcinoma cell lines. Cell Cycle. 2011, 10: 1968-1977. 10.4161/cc.10.12.15825.

    CAS  PubMed  Google Scholar 

83. Hazzalin CA, Mahadevan LC: Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: analysis at c-fos and c-jun. PLoS Biol. 2005, 3: e393-10.1371/journal.pbio.0030393.

    PubMed Central  PubMed  Google Scholar 

84. Zupkovitz G, Tischler J, Posch M, Sadzak I, Ramsauer K, Egger G, Grausenburger R, Schweifer N, Chiocca S, Decker T, Seiser C: Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol Cell Biol. 2006, 26: 7913-7928. 10.1128/MCB.01220-06.

    PubMed Central  CAS  PubMed  Google Scholar 

85. Smith CL: A shifting paradigm: histone deacetylases and transcriptional activation. Bioessays. 2008, 30: 15-24. 10.1002/bies.20687.

    CAS  PubMed  Google Scholar 

86. Lee SC, Magklara A, Smith CL: HDAC activity is required for efficient core promoter function at the mouse mammary tumor virus promoter. J Biomed Biotechnol. 2011, 2011: 416905-

    PubMed Central  PubMed  Google Scholar 

87. Qiu Y, Zhao Y, Becker M, John S, Parekh BS, Huang S, Hendarwanto A, Martinez ED, Chen Y, Lu H, Adkins NL, Stavreva DA, Wiench M, Georgel PT, Schiltz RL, Hager GL: HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell. 2006, 22: 669-679. 10.1016/j.molcel.2006.04.019.

    CAS  PubMed  Google Scholar 

88. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC: Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 2006, 66: 1277-1281. 10.1158/0008-5472.CAN-05-3632.

    CAS  PubMed  Google Scholar 

89. Iorio MV, Piovan C, Croce CM: Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta. 2010, 1799: 694-701.

    CAS  PubMed  Google Scholar 

90. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K: MicroRNAs and epigenetics. FEBS J. 2011, 278: 1598-1609. 10.1111/j.1742-4658.2011.08089.x.

    CAS  PubMed  Google Scholar 

91. Lujambio A, Esteller M: How epigenetics can explain human metastasis: a new role for microRNAs. Cell Cycle. 2009, 8: 377-382. 10.4161/cc.8.3.7526.

    CAS  PubMed  Google Scholar 

92. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, Garcia-Foncillas J: Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer. 2009, 125: 2737-2743. 10.1002/ijc.24638.

    CAS  PubMed  Google Scholar 

93. Lee EM, Shin S, Cha HJ, Yoon Y, Bae S, Jung JH, Lee SM, Lee SJ, Park IC, Jin YW, An S: Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int J Mol Med. 2009, 24: 45-50.

    CAS  PubMed  Google Scholar 

94. Zhang S, Cai X, Huang F, Zhong W, Yu Z: Effect of trichostatin A on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. Exp Oncol. 2008, 30: 265-268.

    CAS  PubMed  Google Scholar 

95. Li X, Liu J, Zhou R, Huang S, Huang S, Chen XM: Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. Br J Haematol. 2010, 148: 69-79. 10.1111/j.1365-2141.2009.07920.x.

    CAS  PubMed  Google Scholar 

96. Fazi F, Racanicchi S, Zardo G, Starnes LM, Mancini M, Travaglini L, Diverio D, Ammatuna E, Cimino G, Lo-Coco F, Grignani F, Nervi C: Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell. 2007, 12: 457-466. 10.1016/j.ccr.2007.09.020.

    CAS  PubMed  Google Scholar 

97. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, Dahiya R: miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene. 2009, 28: 1714-1724. 10.1038/onc.2009.19.

    CAS  PubMed  Google Scholar 

98. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST: Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 2008, 68: 5049-5058. 10.1158/0008-5472.CAN-07-6655.

    PubMed Central  CAS  PubMed  Google Scholar 

99. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, Clark I, Dalmay T: The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006, 580: 4214-4217. 10.1016/j.febslet.2006.06.080.

    CAS  PubMed  Google Scholar 

100. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ: The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006, 38: 228-233. 10.1038/ng1725.

     PubMed Central  CAS  PubMed  Google Scholar 

101. Gonzalez S, Pisano DG, Serrano M: Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs. Cell Cycle. 2008, 7: 2601-2608. 10.4161/cc.7.16.6541.

     CAS  PubMed  Google Scholar 

102. Kim DH, Saetrom P, Snøve O, Rossi JJ: MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci USA. 2008, 105: 16230-16235. 10.1073/pnas.0808830105.

     PubMed Central  CAS  PubMed  Google Scholar 

103. Suzuki K, Kelleher AD: Transcriptional regulation by promoter targeted RNAs. Curr Top Med Chem. 2009, 9: 1079-1087. 10.2174/156802609789630875.

     CAS  PubMed  Google Scholar 

104. Turner AM, Morris KV: Controlling transcription with noncoding RNAs in mammalian cells. Biotechniques. 2010, 48: ix-xvi.

     CAS  PubMed  Google Scholar 

105. Suzuki K, Juelich T, Lim H, Ishida T, Watanebe T, Cooper DA, Rao S, Kelleher AD: Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region. J Biol Chem. 2008, 283: 23353-23363. 10.1074/jbc.M709651200.

     PubMed Central  CAS  PubMed  Google Scholar 

106. Mattick JS: The central role of RNA in human development and cognition. FEBS Lett. 2011, 585: 1600-1616. 10.1016/j.febslet.2011.05.001.

     CAS  PubMed  Google Scholar 

107. Rodríguez-Campos A, Azorín F: RNA is an integral component of chromatin that contributes to its structural organization. PLoS One. 2007, 2: e1182-10.1371/journal.pone.0001182.

     PubMed Central  PubMed  Google Scholar 

108. Brandl A, Heinzel T, Krämer OH: Histone deacetylases: salesmen and customers in the post-translational modification market. Biol Cell. 2009, 101: 193-205. 10.1042/BC20080158.

     CAS  PubMed  Google Scholar 

109. Segré CV, Chiocca S: Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2. J Biomed Biotechnol. 2011, 2011: 690848-

     PubMed Central  PubMed  Google Scholar 

110. Pflum MK, Tong JK, Lane WS, Schreiber SL: Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J Biol Chem. 2001, 276: 47733-47741. 10.1074/jbc.M105590200.

     CAS  PubMed  Google Scholar 

111. Sun JM, Chen HY, Moniwa M, Litchfield DW, Seto E, Davie JR: The transcriptional repressor Sp3 is associated with CK2 phosphorylated histone deacetylase 2. J Biol Chem. 2002, 277: 35783-35786. 10.1074/jbc.C200378200.

     CAS  PubMed  Google Scholar 

112. Galasinski SC, Resing KA, Goodrich JA, Ahn NG: Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem. 2002, 277: 19618-19626. 10.1074/jbc.M201174200.

     CAS  PubMed  Google Scholar 

113. Zhang X, Ozawa Y, Lee H, Wen YD, Tan TH, Wadzinski BE, Seto E: Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 2005, 19: 827-839. 10.1101/gad.1286005.

     PubMed Central  CAS  PubMed  Google Scholar 

114. Rajendran P, Delage B, Dashwood WM, Yu TW, Wuth B, Williams DE, Ho E, Dashwood RH: Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol Cancer. 2011, 10: 68-10.1186/1476-4598-10-68.

     PubMed Central  CAS  PubMed  Google Scholar 

115. Barnes PJ: Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol. 2009, 71: 451-464. 10.1146/annurev.physiol.010908.163257.

     CAS  PubMed  Google Scholar 

116. Adenuga D, Yao H, March TH, Seagrave J, Rahman I: Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol. 2009, 40: 464-473.

     PubMed Central  CAS  PubMed  Google Scholar 

117. Roche N, Marthan R, Berger P, Chambellan A, Chanez P, Aguilaniu B, Brillet PY, Burgel PR, Chaouat A, Devillier P, Escamilla R, Louis R, Mal H, Muir JF, Pérez T, Similowski T, Wallaert B, Aubier M: Beyond corticosteroids: future prospects in the management of inflammation in COPD. Eur Respir Rev. 2011, 20: 175-182. 10.1183/09059180.00004211.

     CAS  PubMed  Google Scholar 

118. Chung KF, Marwick JA: Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci. 2010, 1203: 85-91. 10.1111/j.1749-6632.2010.05600.x.

     CAS  PubMed  Google Scholar 

119. Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK, Shia WJ, Anderson S, Yates J, Washburn MP, Workman JL: Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell. 2005, 123: 581-592. 10.1016/j.cell.2005.10.023.

     CAS  PubMed  Google Scholar 

120. Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR, Schuldiner M, Chin K, Punna T, Thompson NJ, Boone C, Emili A, Weissman JS, Hughes TR, Strahl BD, Grunstein M, Greenblatt JF, Buratowski S, Krogan NJ: Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell. 2005, 123: 593-605. 10.1016/j.cell.2005.10.025.

     CAS  PubMed  Google Scholar 

121. Li B, Gogol M, Carey M, Lee D, Seidel C, Workman JL: Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin. Science. 2007, 316: 1050-1054. 10.1126/science.1139004.

     CAS  PubMed  Google Scholar 

122. Jelinic P, Pellegrino J, David G: A novel mammalian complex containing Sin3B mitigates histone acetylation and RNA polymerase II progression within transcribed loci. Mol Cell Biol. 2011, 31: 54-62. 10.1128/MCB.00840-10.

     PubMed Central  CAS  PubMed  Google Scholar 

123. Hnilicová J, Hozeifi S, Dušková E, Icha J, Tománková T, Staněk D: Histone deacetylase activity modulates alternative splicing. PLoS One. 2011, 6: e16727-10.1371/journal.pone.0016727.

     PubMed Central  PubMed  Google Scholar 

124. Fox-Walsh K, Fu XD: Chromatin: the final frontier in splicing regulation?. Dev Cell. 2010, 18: 336-338. 10.1016/j.devcel.2010.03.002.

     CAS  PubMed  Google Scholar 

125. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T: Epigenetics in alternative pre-mRNA splicing. Cell. 2011, 144: 16-26. 10.1016/j.cell.2010.11.056.

     PubMed Central  CAS  PubMed  Google Scholar 

126. Taft RJ, Simons C, Nahkuri S, Oey H, Korbie DJ, Mercer TR, Holst J, Ritchie W, Wong JJ, Rasko JE, Rokhsar DS, Degnan BM, Mattick JS: Nuclear-localized tiny RNAs are associated with transcription initiation and splice sites in metazoans. Nat Struct Mol Biol. 2010, 17: 1030-1034. 10.1038/nsmb.1841.

     CAS  PubMed  Google Scholar 

127. Zhou HL, Hinman MN, Barron VA, Geng C, Zhou G, Luo G, Siegel RE, Lou H: Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner. Proc Natl Acad Sci USA. 2011, 108: E627-E635. 10.1073/pnas.1103344108.

     PubMed Central  CAS  PubMed  Google Scholar 

128. Clayton AL, Hazzalin CA, Mahadevan LC: Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell. 2006, 23: 289-296. 10.1016/j.molcel.2006.06.017.

     CAS  PubMed  Google Scholar 

129. Gunderson FQ, Merkhofer EC, Johnson TL: Dynamic histone acetylation is critical for cotranscriptional spliceosome assembly and spliceosomal rearrangements. Proc Natl Acad Sci USA. 2011, 108: 2004-2009. 10.1073/pnas.1011982108.

     PubMed Central  CAS  PubMed  Google Scholar 

130. Chang J, Varghese DS, Gillam MC, Peyton M, Modi B, Schiltz RL, Girard L, Martinez ED: Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide. Br J Cancer. 2012, 106: 116-125. 10.1038/bjc.2011.532.

     PubMed Central  CAS  PubMed  Google Scholar 

131. Lössner C, Meier J, Warnken U, Rogers MA, Lichter P, Pscherer A, Schnölzer M: Quantitative proteomics identify novel miR-155 target proteins. PLoS One. 2011, 6: e22146-10.1371/journal.pone.0022146.

     PubMed Central  PubMed  Google Scholar 

Page 2

Class I HDAC1-HDAC2 multiprotein complexes. Multiprotein complexes containing HDAC1-HDAC2 homo- or heterodimers are shown. HDAC2 is shown as phosphorylated, which is a requirement for multiprotein complex formation. Phosphorylation is indicated by a red-outlined yellow triangle.